4-(4-nitro-1H-pyrazol-1-yl)butanenitrile, 95.0%, 1g

(3,3-difluoropiperidin-4-yl)methanol hydrochloride, 95.0%, 500mg

Methyl m-Toluate>98.0%(GC)500mL

Oxetan-3-ylmethanamine>95.0%(GC)200mg

Nitrilotriacetic acid (trisodium salt monohydrate), 97%, 10g

3-Amino-2-naphthoic acid, 97.0%, 5g

(R)-Oxiran-2-ylmethanol, 95.0%, 25g

Adamantanol, min. 99%, for synthesis, 250 g, glass packaging

1-(3-chloro-2-methylphenyl)-5-phenyl-4,5-dihydro-1H-pyrazole-3-carboxylic acid, 95.0%, 2g

2,3,4,5-Tetrachloropyridine, 95.0%, 250mg

Fmoc-b-cyclobutyl-L-alanine, 99.0%, 10g

SPIRO[3H-INDOLE-3,4'-PIPERIDINE]-1'-CARBOXYLIC ACID, 1,2-DIHYDRO-4-(TRIFLUOROMETHYL)-, 1,1-DIMETHYLETHYL ESTER, 95.0%, 1g

(6-Methoxypyridin-2-yl)methanamine dihydrochloride, 95.0%, 100mg